$1.34
2.69% today
Nasdaq, Aug 12, 09:16 pm CET
ISIN
US68375N1037
Symbol
OPK

OPKO Health, Inc. Stock price

$1.30
-0.05 3.70% 1M
-0.32 19.75% 6M
-0.17 11.56% YTD
-0.20 13.33% 1Y
-1.20 48.00% 3Y
-3.67 73.84% 5Y
-12.15 90.33% 10Y
+0.92 242.11% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
+0.05 4.00%

Key metrics

Basic
Market capitalization
$1.0b
Enterprise Value
$1.1b
Net debt
$76.8m
Cash
$271.7m
Shares outstanding
779.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
1.6 | 1.6
EV/Sales
1.7 | 1.7
EV/FCF
negative
P/B
0.8
Financial Health
Equity Ratio
62.1%
Return on Equity
-3.9%
ROCE
-8.1%
ROIC
-10.4%
Debt/Equity
0.3
Financials (TTM | estimate)
Revenue
$664.0m | $656.0m
EBITDA
$-66.0m | $-102.8m
EBIT
$-146.1m | $-233.0m
Net Income
$-177.1m | $-274.3m
Free Cash Flow
$-259.3m
Growth (TTM | estimate)
Revenue
-7.3% | -8.0%
EBITDA
63.7% | 46.2%
EBIT
45.2% | 14.8%
Net Income
27.1% | -415.5%
Free Cash Flow
-201.4%
Margin (TTM | estimate)
Gross
32.7%
EBITDA
-9.9% | -15.7%
EBIT
-22.0%
Net
-26.7% | -41.8%
Free Cash Flow
-39.1%
More
EPS
$-0.2
FCF per Share
$-0.3
Short interest
7.2%
Employees
3k
Rev per Employee
$240.0k
Show more

Is OPKO Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

OPKO Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a OPKO Health, Inc. forecast:

9x Buy
90%
1x Hold
10%

Analyst Opinions

10 Analysts have issued a OPKO Health, Inc. forecast:

Buy
90%
Hold
10%

Financial data from OPKO Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
664 664
7% 7%
100%
- Direct Costs 447 447
16% 16%
67%
217 217
16% 16%
33%
- Selling and Administrative Expenses 284 284
0% 0%
43%
- Research and Development Expense 120 120
42% 42%
18%
-66 -66
64% 64%
-10%
- Depreciation and Amortization 80 80
6% 6%
12%
EBIT (Operating Income) EBIT -146 -146
45% 45%
-22%
Net Profit -177 -177
27% 27%
-27%

In millions USD.

Don't miss a Thing! We will send you all news about OPKO Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

OPKO Health, Inc. Stock News

Neutral
The Motley Fool
11 days ago
Opko Health (OPK) Q2 Revenue Falls 14%
Neutral
Seeking Alpha
12 days ago
OPKO Health, Inc. (NASDAQ:OPK ) Q2 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Adam E. Logal - Senior VP & CFO Elias Adam Zerhouni - President & Vice Chairman Phillip Frost - Chairman & CEO Yvonne Briggs - LHA Investor Relations Conference Call Participants Edward Andrew Tenthoff - Piper Sandler & Co., Research Division I-Eh Jen - Laidlaw & Company (UK) Ltd.
Neutral
GlobeNewsWire
12 days ago
MIAMI, July 31, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2025. Highlights from the second quarter of 2025 and recent weeks include the following: Merck advanced Phase 1 Epstein-Barr virus vaccine trial ( NCT06655324 ).
More OPKO Health, Inc. News

Company Profile

OPKO Health, Inc. engages in the provision of healthcare services. It operates through the following segments: Diagnostics, Pharmaceuticals, and Corporate. The Diagnostics segment include clinical laboratory operations of BioReference, as well as point-of-care operations. The Pharmaceuticals segment includes comprises pharmaceutical operations in Chile, Mexico, Ireland, Israel, and Spain and pharmaceutical research and development operations. The company was founded in October 1991 and is headquartered in Miami, FL.

Head office United States
CEO Phillip Frost
Employees 2,997
Founded 1991
Website www.opko.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today